Caption Management, LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$5,729,900
+201.6%
110,000
+266.7%
0.09%
+158.8%
Q2 2023$1,899,600
-41.5%
30,000
-50.0%
0.03%
-45.2%
Q1 2023$3,249,000
+109.5%
60,000
+104.7%
0.06%
+158.3%
Q4 2022$1,550,821
+40.0%
29,305
+23.1%
0.02%
+60.0%
Q3 2022$1,108,000
-85.8%
23,805
-82.6%
0.02%
-86.1%
Q2 2022$7,826,000
-63.6%
137,100
-66.7%
0.11%
-55.2%
Q4 2021$21,529,000
+235.4%
411,344
+138.9%
0.24%
+230.1%
Q3 2021$6,419,000
+20.6%
172,179
+32.1%
0.07%
+5.8%
Q2 2021$5,321,000
+41.3%
130,360
+17.4%
0.07%
-14.8%
Q1 2021$3,765,000
+92.5%
111,000
+80.5%
0.08%
+80.0%
Q4 2020$1,956,000
+27.8%
61,500
+3.1%
0.04%
+25.0%
Q3 2020$1,531,000
-94.6%
59,673
-94.6%
0.04%
-96.2%
Q2 2020$28,196,000
+1155.4%
1,098,450
+651.8%
0.94%
+639.4%
Q1 2020$2,246,000
-97.0%
146,100
-93.4%
0.13%
-95.0%
Q4 2019$75,392,000
+652.0%
2,197,300
+63.7%
2.53%
+385.2%
Q3 2019$10,026,000
+82.2%
1,342,100
+216.5%
0.52%
+88.4%
Q2 2019$5,502,000
+40.5%
424,000
+31.9%
0.28%
+28.2%
Q1 2019$3,917,000321,5000.22%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders